Evaluating Vaccine Efficacy Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection is a research paper published in Clinical Infectious Diseases (2021). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 AI029168
National Institutes of Health
Grant: R01 GM124104
National Institutes of Health
Grant: P01 CA142538
National Institutes of Health
Grant: UM1 AI068635
NCI NIH HHS
Grant: P50 CA058223
National Institutes of Health
Grant: 5R01AI029168-22
Statistical Issues in AIDS Research
National Institutes of Health
Grant: 5R01GM124104-07
Statistical and Machine Learning Methods to Improve Dynamic Treatment Regimens Estimation Using Real World Data.
National Institutes of Health
Grant: 5P01CA142538-09
Statistical Methods for Cancer Clinical Trials
National Institutes of Health
Grant: 3UM1AI068635-17S4
CoVPN 3001 - A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Adults.
FWCI
0.81
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals